Related Experiment Video

Updated: Jun 27, 2025

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
11:12

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation

Published on: July 16, 2014

22.5K

Comment on: "A Transatlantic Viewpoint on the Role of Pallidal Stimulation for Parkinson's Disease"

Tao Xie1, Peter C Warnke2

  • 1Department of Neurology, University of Chicago Medicine, Chicago, Illinois, USA.

Movement Disorders : Official Journal of the Movement Disorder Society
|April 25, 2024
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

A Novel Approach to Assess Motor Outcome of Deep Brain Stimulation Effects in the Hemiparkinsonian Rat: Staircase and Cylinder Test
07:14

A Novel Approach to Assess Motor Outcome of Deep Brain Stimulation Effects in the Hemiparkinsonian Rat: Staircase and Cylinder Test

Published on: May 31, 2016

14.7K
Targeting Neuronal Fiber Tracts for Deep Brain Stimulation Therapy Using Interactive, Patient-Specific Models
14:14

Targeting Neuronal Fiber Tracts for Deep Brain Stimulation Therapy Using Interactive, Patient-Specific Models

Published on: August 12, 2018

8.9K

Related Experiment Videos

Last Updated: Jun 27, 2025

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
11:12

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation

Published on: July 16, 2014

22.5K
A Novel Approach to Assess Motor Outcome of Deep Brain Stimulation Effects in the Hemiparkinsonian Rat: Staircase and Cylinder Test
07:14

A Novel Approach to Assess Motor Outcome of Deep Brain Stimulation Effects in the Hemiparkinsonian Rat: Staircase and Cylinder Test

Published on: May 31, 2016

14.7K
Targeting Neuronal Fiber Tracts for Deep Brain Stimulation Therapy Using Interactive, Patient-Specific Models
14:14

Targeting Neuronal Fiber Tracts for Deep Brain Stimulation Therapy Using Interactive, Patient-Specific Models

Published on: August 12, 2018

8.9K

Related Concept Videos

Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

264
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
264
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

537
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
537

Articles linked to this work by shared authors, journal, and citation graph.

Clinical trial barriers in neurostimulation for pediatric drug-resistant epilepsy.

Epileptic disorders : international epilepsy journal with videotape·2026

Long-term safety and efficacy of intracortical microstimulation in humans.

Science translational medicine·2026

Intracortical microstimulation in humans: a decade of safety and efficacy.

medRxiv : the preprint server for health sciences·2025

Closed-loop control of theta oscillations enhances human hippocampal network connectivity.

Nature communications·2025

Tactile edges and motion via patterned microstimulation of the human somatosensory cortex.

Science (New York, N.Y.)·2025

A Roadmap for Implanting Electrode Arrays to Evoke Tactile Sensations Through Intracortical Stimulation.

Human brain mapping·2024

Directional Adaptive Deep Brain Stimulation: An Initial Report of Safety, Tolerability, and Effectiveness.

Movement disorders : official journal of the Movement Disorder Society·2026

Timing of Deep Brain Stimulation and Cognitive Trajectories in GBA1-Associated Parkinson's Disease.

Movement disorders : official journal of the Movement Disorder Society·2026

α-Synuclein Seeding Discriminates Between LRRK2 G2019S Variant Carriers with and Without Parkinson's Disease.

Movement disorders : official journal of the Movement Disorder Society·2026

Structural Brain and Spinal Cord Signature of Spinocerebellar Ataxia 27B: A Multisite MRI-Based Study.

Movement disorders : official journal of the Movement Disorder Society·2026

Lewy Body Disease Across Aging: Clinical and Neuropathological Correlates in a Population Brain Bank.

Movement disorders : official journal of the Movement Disorder Society·2026

Multimodal Magnetic Resonance Imaging and Machine Learning Uncovers Distinct Progression Patterns in Friedreich Ataxia.

Movement disorders : official journal of the Movement Disorder Society·2026

Integrative Network Toxicology Identifies NFKB1 and KIF11 as Candidate Genes Associated with 2-Hydroxyphenanthrene in the Context of Psoriasis.

Clinical, cosmetic and investigational dermatology·2026

Network toxicology, molecular docking and molecular dynamics simulations for bisphenol A neurotoxicity in depression pathogenesis.

PloS one·2026

Small airway dysfunction as a functional barrier to spirometry-defined clinical remission in severe asthma treated with biologic therapies.

The World Allergy Organization journal·2026

Cannabinoid modulation of central amygdala population dynamics during threat investigation.

Nature communications·2026

Development and assessment of an artificial intelligence-based tool for scoring lesion severity in generalized pustular psoriasis clinical images.

JID innovations : skin science from molecules to population health·2026

In vivo detection of pathologic α- synuclein and TDP-43 in the skin and olfactory mucosa of a patient with Parkinson's disease-like phenotype carrying the p.Thr272Serfs*10 GRN mutation.

Molecular neurodegeneration·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us